Resources

Selected
  • 昊华科技2024年商誉
Type of publications
Regions
Diseases
380 results found
2024 ∙ ATAGI
ATAGI statement on the administration of seasonal influenza vaccines in 2024
Recommendation Western Pacific Australia Influenza
Download:
2024 ∙ SAGE
Malaria vaccine: WHO position paper – May 2024
Position paper Malaria
Download:
2024 ∙ SAGE
WHO position paper on dengue vaccines – May 2024
Position paper Qdenga Dengue
Download:
2024 ∙ JCVI
JCVI statement on COVID-19 vaccination in spring 2024 and considerations on future COVID-19 vaccination
Recommendation Europe United Kingdom COVID-19
Download:
2024
Considerations to inform country COVID-19 vaccination decision-making
COVID-19
Download:
2024 ∙ NACI
Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19
Recommendation Americas Canada Older adults COVID-19
Download:
2024
Meningococcal vaccines: WHO position paper on the use of multivalent meningococcal conjugate vaccines in countries of the African meningitis belt, January 2024
Position paper Meningococcal disease
Download:
2023 ∙ Ma, J. Chen, L. Tang, S. Shi, Y.
Efficacy and safety of respiratory syncytial virus vaccination during pregnancy to prevent lower respiratory tract illness in newborns and infants: a systematic review and meta-analysis of randomized controlled trials
Pregnant women RSV (Respiratory syncytial virus) Efficacy/effectiveness Safety
Rating:
Low
2023 ∙ Zahhar, J. A. Salamatullah, H. K. Almutairi, M. B. Faidah, D. E. Afif, L. M. Banjar, T. A. Alansari, N. Betar, M. Alghamdi, S. Makkawi, S.
Influenza vaccine effect on risk of stroke occurrence: a systematic review and meta-analysis
Adults Older adults Influenza Efficacy/effectiveness
Rating:
Low
2023 ∙ Cheng, M. Q. Li, R. Weng, Z. Y. Song, G.
Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
Loading...